Learn more

THE GENERAL HOSPITAL CORP D/B/A MASSACHUSETTS GENERAL HOSPITAL

Overview
  • Total Patents
    38
  • GoodIP Patent Rank
    101,603
  • Filing trend
    0.0%
About

THE GENERAL HOSPITAL CORP D/B/A MASSACHUSETTS GENERAL HOSPITAL has a total of 38 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2005. It filed its patents most often in EPO (European Patent Office), Australia and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are UNIV GENEVE, ASTRA AG and SAMSUNG LIFE PUBLIC WELFARE FO.

Patent filings per year

Chart showing THE GENERAL HOSPITAL CORP D/B/A MASSACHUSETTS GENERAL HOSPITALs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Muratoglu Orhun K 7
#2 Zumbrunn Thomas 6
#3 Rubash Harry E 6
#4 Varadarajan Kartik Mangudi 6
#5 Yu Yong-Ming 4
#6 Martyn Jeevendra A 4
#7 Rahme Laurence 4
#8 Tompkins Ronald G 3
#9 Li Guoan 3
#10 Malchau Henrik 3

Latest patents

Publication Filing date Title
WO2017139366A1 Methods and compositions relating to engineered microbial cells
WO2017095738A1 Methods and compositions relating to the treatment of benign skin tumors
EP3373929A1 Unit dose formulations for use as an anti-fugetactic agent
US2017169164A1 Phenotype-based chemical screens
EP3294901A1 Autoantigens for diagnosis of rheumatoid arthritis
EP3795694A2 Methods relating to dna-sensing pathway related conditions
BR112015006916A2 Femoral heads, movable inserts, acetabular components and modular joints for orthopedic implants and methods for using femoral heads, movable inserts, acetabular components and modular joints for orthopedic implants
EP2731522A2 Devices for knee joint replacement with anterior cruciate ligament substitution
EP3460064A1 Efficient protein expression in vivo using modified rna (mod-rna)
BR112013002859A2 METHOD AND APPARATUS FOR CELL TREATMENT
BR112012027141A2 ultrasonic compliance zone system
EP3563862A1 D-arg-2'6'-dimethyltyrosine-lys-phe-nh2 for use in the prevention of secondary complications of burn injuries